Metabolism - Clinical and Experimental
Volume 45, Issue 1 , Pages 57-62, January 1996

Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes—clinical and biological correlations

  • S. Labrouche

      Affiliations

    • Corresponding Author InformationAddress reprint requests to S. Labrouche, PhD, Laboratoire d'Hematologie, Hôpital Pellegrin, 33076 Bordeaux Cedex, France.
    • Unité 8, INSERM, Pessac-Bordeaux, France
    • CNRS-URA 1811, Université de Bordeaux II, Bordeaux, France
    • Clinique Médicale et des Maladies infectieuses, Hôpital Pellegrin, Bordeaux, France
  • ,
  • G. Freyburger

      Affiliations

    • Unité 8, INSERM, Pessac-Bordeaux, France
    • CNRS-URA 1811, Université de Bordeaux II, Bordeaux, France
    • Clinique Médicale et des Maladies infectieuses, Hôpital Pellegrin, Bordeaux, France
  • ,
  • H. Gin

      Affiliations

    • Unité 8, INSERM, Pessac-Bordeaux, France
    • CNRS-URA 1811, Université de Bordeaux II, Bordeaux, France
    • Clinique Médicale et des Maladies infectieuses, Hôpital Pellegrin, Bordeaux, France
  • ,
  • M.R. Boisseau

      Affiliations

    • Unité 8, INSERM, Pessac-Bordeaux, France
    • CNRS-URA 1811, Université de Bordeaux II, Bordeaux, France
    • Clinique Médicale et des Maladies infectieuses, Hôpital Pellegrin, Bordeaux, France
  • ,
  • C. Cassagne

      Affiliations

    • Unité 8, INSERM, Pessac-Bordeaux, France
    • CNRS-URA 1811, Université de Bordeaux II, Bordeaux, France
    • Clinique Médicale et des Maladies infectieuses, Hôpital Pellegrin, Bordeaux, France

Received 24 December 1994; accepted 18 April 1995.

Abstract 

A variety of disorders of erythrocyte, platelet, and polymorphonuclear leukocyte (PMN) functions have been described in diabetes. The phospholipid composition of erythrocyte, platelet, and PMN membranes from controls and from type I and II diabetics was investigated in this study. Phospholipids were determined by densitometry using the molybdenum blue reagent. In diabetics, the relative abundance of phosphatidylethanolamine (PE) increased in all cell types studied, whereas those of sphingomyelin (Sph) and phosphatidylcholine (PC) were decreased in platelets and PMN. The percentage of phosphatidylserine (PS) was reduced in erythrocytes but increased in platelets. The level of Sph in PMN was significantly lower in type I than in type II diabetics. Moreover, the longer the duration of diabetes and the poorer the metabolic control, the greater the decrease in Sph. Rheological parameters, which reflect the behavior of red blood cells (RBC), were correlated with the alteration in PE/PS ratio in these cells.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(96)90200-0

Metabolism - Clinical and Experimental
Volume 45, Issue 1 , Pages 57-62, January 1996